Heidi R. Bokesch

12.3k total citations · 1 hit paper
61 papers, 10.9k citations indexed

About

Heidi R. Bokesch is a scholar working on Molecular Biology, Organic Chemistry and Biotechnology. According to data from OpenAlex, Heidi R. Bokesch has authored 61 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 25 papers in Organic Chemistry and 21 papers in Biotechnology. Recurrent topics in Heidi R. Bokesch's work include Marine Sponges and Natural Products (19 papers), Microbial Natural Products and Biosynthesis (12 papers) and Phytochemical compounds biological activities (7 papers). Heidi R. Bokesch is often cited by papers focused on Marine Sponges and Natural Products (19 papers), Microbial Natural Products and Biosynthesis (12 papers) and Phytochemical compounds biological activities (7 papers). Heidi R. Bokesch collaborates with scholars based in United States, China and Switzerland. Heidi R. Bokesch's co-authors include M. R. Boyd, Philip Skehan, jeannette mcmahon, Anne Monks, David T. Vistica, Dominic A. Scudiero, James T. Warren, Ritsa Storeng, Susan Kenney and Tawnya C. McKee and has published in prestigious journals such as PLoS ONE, Journal of Molecular Biology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Heidi R. Bokesch

61 papers receiving 10.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening

1990 8.8k citations Philip Skehan, Ritsa Storeng et al. JNCI Journal of the National Cancer Institute profile →

Peers

Countries citing papers authored by Heidi R. Bokesch

Since Specialization

Citations

This map shows the geographic impact of Heidi R. Bokesch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi R. Bokesch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi R. Bokesch more than expected).

Fields of papers citing papers by Heidi R. Bokesch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi R. Bokesch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi R. Bokesch. The network helps show where Heidi R. Bokesch may publish in the future.

Co-authorship network of co-authors of Heidi R. Bokesch

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi R. Bokesch. A scholar is included among the top collaborators of Heidi R. Bokesch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi R. Bokesch. Heidi R. Bokesch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Molecular Networking Strategy: High-Throughput Screening and Chemical Analysis of Brazilian Cerrado Plant Extracts against Cancer Cells 2021 ·Cells ·(unknown), Daniel P. Demarque, Renata G. Dusi, (unknown), Raimundo Braz‐Filho, Ekaterina I. Goncharova, Heidi R. Bokesch, Kirk R. Gustafson, John A. Beutler, Laila Salmen Espíndola	11
2	Identification of natural product modulators of Merkel cell carcinoma cell growth and survival 2021 ·Scientific Reports ·Emily A. Smith, (unknown), (unknown), (unknown), Ekaterina I. Goncharova, Heidi R. Bokesch, Chang‐Kwon Kim, Karen Wendt, Robert H. Cichewicz, Kirk R. Gustafson, Isaac Brownell, Curtis J. Henrich	4
3	Macrophilones from the Marine Hydroid Macrorhynchia philippina Can Inhibit ERK Cascade Signaling 2018 ·Journal of Natural Products ·Pengcheng Yan, Daniel A. Ritt, (unknown), Heidi R. Bokesch, William C. Reinhold, John S. Schneekloth, Deborah K. Morrison, Kirk R. Gustafson	12
4	Unequivocal determination of caulamidines A and B: application and validation of new tools in the structure elucidation tool box 2017 ·Chemical Science ·Dennis Milanowski, Naoya Oku, Laura K. Cartner, Heidi R. Bokesch, R. Thomas Williamson, Josep Saurí, (unknown), Kirill A. Blinov, Yuanqing Ding, Xing‐Cong Li, Daneel Ferreira, Larry Walker, Shabana I. Khan, Michael T. Davies‐Coleman, James A. Kelley, James B. McMahon, Gary E. Martin, Kirk R. Gustafson	56
5	Macrophilone A: Structure Elucidation, Total Synthesis, and Functional Evaluation of a Biologically Active Iminoquinone from the Marine Hydroid Macrorhynchia philippina 2017 ·Organic Letters ·(unknown), William M. Hewitt, Pengcheng Yan, Heidi R. Bokesch, Megan L. Peach, Marc C. Nicklaus, Barry R. O’Keefe, James B. McMahon, Kirk R. Gustafson, John S. Schneekloth	18
6	Stellettapeptins A and B, HIV-inhibitory cyclic depsipeptides from the marine sponge Stelletta sp. 2015 ·Tetrahedron Letters ·Hee Jae Shin, Mohammad Mamun Ur Rashid, Laura K. Cartner, Heidi R. Bokesch, Jennifer A. Wilson, James B. McMahon, Kirk R. Gustafson	30
7	Characterization of pomiferin triacetate as a novel mTOR and translation inhibitor 2014 ·Biochemical Pharmacology ·(unknown), (unknown), (unknown), Heidi R. Bokesch, Hanyong Chen, (unknown), Zigang Dong, Kirk R. Gustafson, Ricardo M. Biondi, Curtis J. Henrich, James B. McMahon, Nancy H. Colburn, Tobias Schmid, Bernhard Brüne	12
8	Erioflorin Stabilizes the Tumor Suppressor Pdcd4 by Inhibiting Its Interaction with the E3-ligase β-TrCP1 2012 ·PLoS ONE ·(unknown), Heidi R. Bokesch, (unknown), Kathrin Schulz, (unknown), (unknown), Kirk R. Gustafson, Curtis J. Henrich, James B. McMahon, Nancy H. Colburn, Tobias Schmid, Bernhard Brüne	48
9	A selective small-molecule nuclear factor-κB inhibitor from a high-throughput cell-based assay for “activator protein-1 hits” 2009 ·Molecular Cancer Therapeutics ·(unknown), Curtis J. Henrich, Heidi R. Bokesch, Kirk R. Gustafson, James B. McMahon, Alyson R. Baker, Matthew R. Young, Nancy H. Colburn	18
10	New inhibitors of ABCG2 identified by high-throughput screening 2007 ·Molecular Cancer Therapeutics ·Curtis J. Henrich, Robert W. Robey, Heidi R. Bokesch, Susan E. Bates, Suneet Shukla, Suresh V. Ambudkar, Michael Dean, James B. McMahon	57
11	The Novel Fold of Scytovirin Reveals a New Twist For Antiviral Entry Inhibitors 2007 ·Journal of Molecular Biology ·Robert L. McFeeters, Changyun Xiong, Barry R. O’Keefe, Heidi R. Bokesch, James B. McMahon, Daniel M. Ratner, Riccardo Castelli, Peter H. Seeberger, R. Andrew Byrd	38
12	Atomic‐resolution crystal structure of the antiviral lectin scytovirin 2007 ·Protein Science ·Tinoush Moulaei, Istvan Botos, N.E. Ziolkowska, Heidi R. Bokesch, Lauren R. H. Krumpe, Tawnya C. McKee, Barry R. O’Keefe, Zbigniew Dauter, Alexander Wlodawer	28
13	Natural Products Active in Aberrant c‐Kit Signaling 2007 ·Chemical Biology & Drug Design ·Curtis J. Henrich, Ekaterina I. Goncharova, Jennifer A. Wilson, Roberta S. Gardella, Tanya R. Johnson, James B. McMahon, Kentaro Takada, Heidi R. Bokesch, Kirk R. Gustafson	10
14	Anti-HIV Cyclotides 2004 ·Current Protein and Peptide Science ·Kirk R. Gustafson, Tawnya C. McKee, Heidi R. Bokesch	132
15	Oligosaccharide and Glycoprotein Microarrays as Tools in HIV Glycobiology 2004 ·Chemistry & Biology ·Eddie W. Adams, Daniel M. Ratner, Heidi R. Bokesch, James B. McMahon, Barry R. O’Keefe, Peter H. Seeberger	181
16	Isolation and characterization of anti‐HIV peptides from Dorstenia contrajerva and Treculia obovoidea 2004 ·FEBS Letters ·Heidi R. Bokesch, Romila D. Charan, Karina M. Meragelman, John A. Beutler, Roberta S. Gardella, Barry R. O’Keefe, Tawnya C. McKee, James B. McMahon	14
17	Solution Structure of the Cyclotide Palicourein 2004 ·Structure ·(unknown), Norelle L. Daly, Heidi R. Bokesch, Kirk R. Gustafson, David J. Craik	32
18	A Chemical Screening Strategy for the Dereplication and Prioritization of HIV-Inhibitory Aqueous Natural Products Extracts 1993 ·Journal of Natural Products ·John H. Cardellina, Murray H. G. Munro, Richard W. Fuller, Kirk P. Manfredi, Tawnya C. McKee, Mark Tischler, Heidi R. Bokesch, Kirk R. Gustafson, John A. Beutler, M. R. Boyd	70
19	New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening breakdown → 1990 ·JNCI Journal of the National Cancer Institute ·Philip Skehan, Ritsa Storeng, Dominic A. Scudiero, Anne Monks, jeannette mcmahon, David T. Vistica, James T. Warren, Heidi R. Bokesch, Susan Kenney, M. R. Boyd	8784
20	The regulation of sterol metabolism by cell interactions 1987 ·Experimental Cell Research ·Susan Friedman, Heidi R. Bokesch, Philip Skehan	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact